Rhythm Pharmaceuticals Inc (RYTM)

59.60 -0.47 (-0.78%) USD  |  NASDAQ  |  Jan 03, 16:00
59.60 0.00 (0.00%) After-Hours: 20:00
More

Rhythm Pharmaceuticals Research and Development Expense (Quarterly): 37.93M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for RYTM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
MannKind Corp 12.93M
TG Therapeutics Inc 20.14M
Voyager Therapeutics Inc 30.24M
Krystal Biotech Inc 13.51M
NovaBay Pharmaceuticals Inc 0.004M